Intellectual Property India Publishes Patent Application for 'Quinazoline-Based Atr Kinase Inhibitors And A Process For Their Preparation' Filed by Indian Institute Of Technology

MUMBAI, India, Jan. 9 -- Intellectual Property India has published a patent application (202421086843 A) filed by Indian Institute Of Technology, Gandhinagar, Gujarat, on Nov. 11, 2024, for 'quinazoline-based atr kinase inhibitors and a process for their preparation.'

Inventor(s) include Sivapriya Kirubakaran; and Pranav Umesh Bhagwat.

The application for the patent was published on Dec. 12, under issue no. 50/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to quinazoline derivatives and a process for their preparation. In particular, the present disclosure provides quinazoline-based ATR kinase inhibitors having reduced toxicity and better selectivity towards ATR Kinase for cancer therapy. The quinazoline derivatives of the present disclosure have enhanced tolerability in patients with minimized treatment interruptions. The present disclosure also provides a process for the preparation of quinazoline derivatives, which is simple, economical and easy to scale up."

Disclaimer: Curated by HT Syndication.